Not so EEZE: The 'EDHF' antagonist 14, 15 epoxyeicosa-5(Z)-enoic acid has vasodilator properties in mesenteric arteries

European Journal of Pharmacology

Volumn 506, Issue 2, 2004, Pages 165-168

  Harrington, Louise S ^a   Falck, John R ^b   Mitchell, Jane A ^a  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

^b UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

14,15 EEZE; EDHF (Endothelial derived hyperpolarising factor); Hyperpolarisation; Mesenteric artery; mouse; U46619

Indexed keywords

11 NONYLOXYUNDEC 8 ENOIC ACID; 14,15 EPOXYEICOS 5 ENOIC ACID; 15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; ARACHIDIC ACID; ENDOTHELIN 1; METHOXAMINE; POTASSIUM; PROSTAGLANDIN F2; UNCLASSIFIED DRUG; UNDECANOIC ACID; VASODILATOR AGENT;

ANIMAL TISSUE; ARTERY CONSTRICTION; ARTERY DILATATION; ARTICLE; DRUG STABILITY; MALE; MESENTERIC ARTERY; MOUSE; NONHUMAN; PRIORITY JOURNAL;

8,11,14-EICOSATRIENOIC ACID; ANIMALS; BIOLOGICAL FACTORS; MALE; MESENTERIC ARTERIES; MICE; MICE, INBRED C57BL; VASOCONSTRICTOR AGENTS; VASODILATOR AGENTS;

EID: 9944228231     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2004.09.062     Document Type: Article

References (9)

1. S.L. Archer, F.S. Gragasin, X. Wu, S. Wang, S. McMurtry, D.H. Kim, M. Platonov, A. Koshal, K. Hashimoto, W.B. Campbell, J.R. Falck, and E.D. Michelakis Endothelium-derived hyperpolarizing factor in human internal mammary artery is 11, 12-epoxyeicosatrienoic acid and causes relaxation by activating smooth muscle BK(Ca) channels Circulation 107 2003 769 776
2. W.B. Campbell, D. Gebremedhin, P.F. Pratt, and D.R. Harder Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors Circ. Res. 78 1996 415 423
3. J.R. Falck, U.M. Krishna, Y.K. Reddy, P.S. Kumar, K.M. Reddy, S.B. Hittner, C. Deeter, K.K. Sharma, K.M. Gauthier, and W.B. Campbell Comparison of vasodilatory properties of 14,15-EET analogs: structural requirements for dilation Am. J. Physiol., Heart Circ. Physiol. 284 2003 H337 H349
4. J.R. Falck, L. Reddy, Y. Reddy, M. Bondlela, U. Krishna, Ji, J. Sun, and J.K. Liao 11, 12-Epoxyeicosatrienoic acid (11, 12-EET): structural determinants for inhibition of TNF-a-induced VCAM-1 expression Bioorg. Med. Chem. Lett. 13 2003 4011 4014
5. B. Fisslthaler, R. Bopp, L. Kiss, M. Potente, D.R. Harder, I. Fleming, and R. Busse Cytochrome P450 2C is an EDHF synthase in coronary arteries Nature 401 1999 493 497
6. K.M. Gauthier, C. Deeter, U.M. Krishna, Y.K. Reddy, M. Bondlela, J.R. Falck, and W.B. Campbell 14,15-Epoxyeicosa-5(Z)-enoic acid: a selective epoxyeicosatrienoic acid antagonist that inhibits endothelium-dependent hyperpolarization and relaxation in coronary arteries Circ. Res. 90 2002 1028 1036
7. M.J. Mulvany, and W. Halpern Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats Circ. Res. 41 1977 19 26
8. C. Van Renterghem, P. Vigne, J. Barhanin, A. Schmid-Alliana, C. Frelin, and M. Lazdunski Molecular mechanism of endothelin-1 action on aortic cells J. Cardiovasc. Pharmacol. 13 Suppl. 5 1989 S186 S187
9. A.P. Zou, J.T. Fleming, J.R. Falck, E.R. Jacobs, D. Gebremedhin, D.R. Harder, and R.J. Roman Stereospecific effects of epoxyeicosatrienoic acids on renal vascular tone and K(+)-channel activity Am. J. Physiol. 270 1996 F822 F832